Main Research and Development Centers
Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.
Andover, Massachusetts
Combining state-of-the-art R&D and Pfizer Global Supply (PGS) facilities with flexible, multi-product manufacturing capabilities, Andover is a key driver of innovation across our biologics discovery, development, and global clinical and commercial supply efforts.
Bothell, WA
Utilizing advanced laboratories and equipment, researchers in Bothell are dedicated to revolutionizing cancer treatment.
Cambridge, Massachusetts
Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.
Groton, Connecticut
Many of the discoveries and innovations that drive the Pfizer pipeline to new potential occur in the world-class research and development laboratories in Groton.
San Diego, CA
With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.
Pearl River, New York
As the global hub for Pfizer Vaccine Research and Development, our Pearl River colleagues have developed and manufactured vaccines and other medicines for more than a century.
St. Louis, MO
An expansive laboratory and manufacturing space, our colleagues focus on the development of potential new medicines to help prevent or treat diseases and conditions.

Clinical Trials
Learn more about the process of joining a clinical trial and find a trial near you.
Go to Pfizer Clinical Trials Site DetailsRelated Articles
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says. Then he got sick.










